Results 31 to 40 of about 182,387 (331)

Contact-inhibited chemotaxis in de novo and sprouting blood-vessel growth [PDF]

open access: yesPLoS Computational Biology 2008, 4(9): e1000163, 2005
Blood vessels form either when dispersed endothelial cells (the cells lining the inner walls of fully-formed blood vessels) organize into a vessel network (vasculogenesis), or by sprouting or splitting of existing blood vessels (angiogenesis). Although they are closely related biologically, no current model explains both phenomena with a single ...
arxiv   +1 more source

Vascular endothelial‐cadherin as a marker of endothelial injury in preclinical Alzheimer disease

open access: yesAnnals of Clinical and Translational Neurology, Volume 9, Issue 12, Page 1926-1940, December 2022., 2022
Abstract Objective Endothelial dysfunction is an early and prevalent pathology in Alzheimer disease (AD). We here investigate the value of vascular endothelial‐cadherin (VEC) as a cerebrospinal fluid (CSF) marker of endothelial injury in preclinical AD.
Rawan Tarawneh   +5 more
wiley   +1 more source

Metalloproteinases and their inhibitors in tumor angiogenesis [PDF]

open access: yesInternational Journal of Cancer, 2005
AbstractAngiogenesis is the process by which new blood vessels are formed from preexisting vasculature. It is an essential feature of the female reproductive cycle, embryonic development and wound repair. Angiogenesis has also been identified as a causal or contributing factor in several pathologies, including cancer, where it is a rate‐limiting step ...
Handsley, M.M., Edwards, D.R.
openaire   +4 more sources

Trisubstituted pyrazolopyrimidines as novel angiogenesis inhibitors. [PDF]

open access: yesPLoS ONE, 2013
Current inhibitors of angiogenesis comprise either therapeutic antibodies (e.g. bevacicumab binding to VEGF-A) or small molecular inhibitors of receptor tyrosin kinases like e.g. sunitinib, which inhibits PDGFR and VEGFR.
Sabine B Weitensteiner   +8 more
doaj   +1 more source

In silico identification of potential natural product inhibitors of human proteases key to SARS-CoV-2 infection [PDF]

open access: yesMolecules 2020, 25(17), 3822, 2020
Presently, there are no approved drugs or vaccines to treat COVID-19 which has spread to over 200 countries and is responsible for over 3,65,000 deaths worldwide. Recent studies have shown that two human proteases, TMPRSS2 and cathepsin L, play a key role in host cell entry of SARS-CoV-2.
arxiv   +1 more source

Questionnaire survey of angiogenesis inhibitor-related oral complications based on a nation-wide study in Japan

open access: yesJournal of Dental Sciences, 2021
Background/purpose: The prevalence of oral adverse events and dental treatments related complications during the molecular targeted drugs therapy remains unclear.
Shin-ichi Yamada   +8 more
doaj  

Irsogladine is a potent inhibitor of angiogenesis [PDF]

open access: yesFEBS Letters, 1993
We describe a novel inhibitor of angiogenesis, Irsogladine, an anti‐ulcer drug. Irsogladine inhibited plasminogen activator synthesis of, and tube formation by, human microvascular endothelial cells in type 1 collagen gel treated with an angiogenic growth factor, EGF.
Kazuki Okamura   +7 more
openaire   +3 more sources

Evaluation of Angiogenesis Inhibitors Using the HUVEC Fibrin Bead Sprouting Assay

open access: yesBio-Protocol, 2016
Angiogenesis, the growth of new blood vessels from pre-existing vessels, is a critical process that occurs during normal development and tumor formation.
Laura Winters   +3 more
doaj   +1 more source

The Angiogenic Balance and Its Implications in Cancer and Cardiovascular Diseases: An Overview

open access: yesMedicina, 2022
Angiogenesis is the process of developing new blood vessels from pre-existing ones. This review summarizes the main features of physiological and pathological angiogenesis and those of angiogenesis activation and inhibition.
Cătălina Ionescu   +7 more
doaj   +1 more source

Acetylcholinesterase inhibitors attenuate angiogenesis [PDF]

open access: yesClinical Science, 2012
Donepezil {(RS)-2-[(1-benzyl-4-piperidyl)methyl]-5,6-dimethoxy-2,3-dihydroinden-1-one} is a reversible acetylcholinesterase inhibitor and used for treatment of patients with AD (Alzheimer's disease). Recent studies showed that treatment with donepezil reduced production of inflammatory cytokines in PBMCs (peripheral blood mononuclear cells).
Aya Kamiharaguchi   +8 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy